SCHEMBL9409728

SCHEMBL9409728

O=C(O)Oc1cccc2ncc(-c3ccccc3)nc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.48
PARP2 Q9UGN5 1/20 0.45
SMN1; SMN2 Q16637 6/20 0.44
MAPT P10636 5/20 0.44
ALDH1A1 P00352 1/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
RAB9A P51151 7/20 0.44
NPC1 O15118 6/20 0.44
KMT2A Q03164 5/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
BCHE P06276 1/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.42
ESR1 P03372 1/20 0.42
HTT P42858 1/20 0.42
USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1034874 0.78 PARP1 (0.62) PARP1PARP2SMN1; SMN2ALDH1A1KMT2A
SCHEMBL317958 0.77 NQO2 (0.58) SMN1; SMN2MAPTALDH1A1GAAHDAC6
SCHEMBL7111338 0.75 PARP1 (0.80) PARP1PARP2ALDH1A1
SCHEMBL31353202 0.75 PARP1 (0.59) PARP1PARP2SMN1; SMN2ALDH1A1RAB9A
SCHEMBL8677705 0.75 TLR9 (0.45) PARP1PARP2SMN1; SMN2MAPTALDH1A1
SCHEMBL9225858 0.75 TDO2 (0.49) PARP1SMN1; SMN2MAPTALDH1A1RAB9A
SCHEMBL9885994 0.73 MET (0.54) PARP1PARP2SMN1; SMN2MAPTALDH1A1
SCHEMBL3961416 0.73 LMNA (0.46) SMN1; SMN2MAPTALDH1A1GAAHDAC6
SCHEMBL8967010 0.72 MET (0.44) PARP1MAPTALDH1A1HTTNPSR1
SCHEMBL13019019 0.72 NPC1 (0.53) PARP1PARP2SMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0630895-A1 4-Bicyclic substituted dihydropyridines, process for their preparation and their use in medicaments BAYER AG (DE) 1994-12-28 EP disclosed